Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-039431)

Filing Details

Accession Number:: 0001209191-12-039431
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-27 20:21:37
Reporting Period:: 2012-07-25

Filing Date:: 2012-07-27
Accepted Time:: 2012-07-27 20:21:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1012140	Onyx Pharmaceuticals Inc	ONXX	Biological Products, (No Disgnostic Substances) (2836)	943154463

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1312622	I Kaye Foster-Cheek	C/O Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080	Svp, Global Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-07-25	2,335	$73.97	43,574	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 plan.
The shares were sold to cover a tax obligation realized by the reporting person that arose in connection with the vesting of stock awards granted to the reporting person under the Issuer's 2005 Equity Incentive Plan.